🟢 Xenetic Biosciences is trading 19.4% up in after-hours trading with no identified company-specific catalyst

Xenetic Biosciences is trading at $2.06, up 19.36% in after-hours trading; no direct catalyst has been established.

• No new company-specific announcement dated October 26 was identified. The latest reported company news was the October 15 first-patient dosing update for its DNase-and-CAR-T study, which predates the move.
• The regular session closed at $1.85, up 7.56%. Supplied market context showed broad indexes higher; that may be supportive background but does not establish the after-hours cause.